Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07763665 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Anti-inflammatory Effect of MgSO₄ in Patients With Moderate Traumatic Brain Injury by Measurming Nucleotide-binding Oligomerization Domain-Like Receptor Pyrin Domain-containing 3 (NLRP3) Inflammasome-a Multiprotein Complex

StatusNot Yet Recruiting
PhasePhase 4
Started2026-10-01
View on ClinicalTrials.gov ↗
1,604 trials monitored
See 18 trials at risk
The primary objective of this study is to evaluate the biochemical efficacy of Magnesium Sulfate (MgSO₄) as an anti-inflammatory therapeutic agent in patients suffering from moderate traumatic brain injury (TBI) at Assiut University Hospitals by measuring Nucleotide-binding oligomerization domain-Like Receptor Pyrin domain-containing 3 (NLRP3) inflammasome-a multiprotein complex.
Trial Details
NCT Number NCT07763665
Lead Sponsor Assiut University
Conditions Traumatic Brain Injuries
Enrollment 64 participants
Start Date 2026-10-01
Primary Completion 2027-11-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-13